Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Eagle Pharma Enters into R&D Agreement with United States Army Medical Research Institute of Chemical Defense 11
Eagle Pharma Enters into Agreement with National Institutes of Health 12
Eagle Pharma Enters into Co-Development Agreement with Albany Molecular Research 13
Arsia Therapeutics Enters into Research Agreement with Biogen 14
Eagle Pharma Enters into Agreement with Spectrum Pharma 15
Licensing Agreements 16
Symbio Pharma Enters into Licensing Agreement with Eagle Pharma 16
Eagle Pharma Enters into Licensing Agreement with Teikoku Pharma 17
Teva Pharma Amends Licensing Agreement with Eagle Pharma for EP-3102 18
Equity Offering 19
Eagle Pharma Raises USD54.3 Million in Public Offering of Shares 19
Eagle Pharma Completes IPO For US$50.3 Million 21
Asset Transactions 22
Eagle Pharma Divests Diclofenac for USD1.75 Million 22
Acquisition 23
Eagle Pharma Acquires Arsia Therapeutics 23
Eagle Pharmaceuticals Inc – Key Competitors 24
Eagle Pharmaceuticals Inc – Key Employees 25
Eagle Pharmaceuticals Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Nov 01, 2018: Eagle Pharmaceuticals reports third quarter 2018 results 27
Aug 07, 2018: Eagle Pharmaceuticals reports second quarter 2018 results 29
May 10, 2018: Eagle Pharmaceuticals Reports First Quarter 2018 Results 31
Feb 26, 2018: Eagle Pharmaceuticals Reports Fourth Quarter 2017 Financial Results 33
Nov 08, 2017: Eagle Pharmaceuticals Reports Third Quarter 2017 Results 35
Aug 09, 2017: Eagle Pharmaceuticals Reports Second Quarter 2017 Results 37
May 08, 2017: Eagle Pharmaceuticals Reports First Quarter 2017 Results 39
Mar 01, 2017: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 40
Corporate Communications 42
Sep 26, 2018: Eagle appoints David Pernock to position of Chief Operating Officer 42
May 15, 2017: Eagle Pharmaceuticals Appoints Pete A. Meyers as Chief Financial Officer 43
Mar 16, 2017: Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors 44
Product Approvals 45
Mar 27, 2017: FDA Grants Priority Review for Eagle Pharmaceuticals Ryanodex NDA for the Treatment of Exertional Heat Stroke 45
Jan 23, 2017: Eagle Pharmaceuticals Completes NDA Submission for Ryanodex for Exertional Heat Stroke to FDA 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eagle Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eagle Pharma Enters into R&D Agreement with United States Army Medical Research Institute of Chemical Defense 11
Eagle Pharma Enters into Agreement with National Institutes of Health 12
Eagle Pharma Enters into Co-Development Agreement with Albany Molecular Research 13
Arsia Therapeutics Enters into Research Agreement with Biogen 14
Eagle Pharma Enters into Agreement with Spectrum Pharma 15
Symbio Pharma Enters into Licensing Agreement with Eagle Pharma 16
Eagle Pharma Enters into Licensing Agreement with Teikoku Pharma 17
Teva Pharma Amends Licensing Agreement with Eagle Pharma for EP-3102 18
Eagle Pharma Raises USD54.3 Million in Public Offering of Shares 19
Eagle Pharma Completes IPO For US$50.3 Million 21
Eagle Pharma Divests Diclofenac for USD1.75 Million 22
Eagle Pharma Acquires Arsia Therapeutics 23
Eagle Pharmaceuticals Inc, Key Competitors 24
Eagle Pharmaceuticals Inc, Key Employees 25
Eagle Pharmaceuticals Inc, Subsidiaries 26
List of Figures
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9